Alembic Pharma gains after receiving USFDA nod for Betamethasone Valerate Foam 0 26.08.2024 07:25 Business Standard Alembic Pharmaceuticals jumped 2.25% to Rs 1,125.35 after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Betamethasone Valerate Foam. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
